KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Change in Cash (2016 - 2025)

Historic Change in Cash for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $61.1 million.

  • Dynavax Technologies' Change in Cash rose 79381.67% to $61.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.9 million, marking a year-over-year increase of 21642.26%. This contributed to the annual value of -$54.4 million for FY2024, which is 531.8% down from last year.
  • As of Q3 2025, Dynavax Technologies' Change in Cash stood at $61.1 million, which was up 79381.67% from $47.4 million recorded in Q2 2025.
  • In the past 5 years, Dynavax Technologies' Change in Cash ranged from a high of $189.8 million in Q4 2021 and a low of -$256.8 million during Q1 2022
  • In the last 5 years, Dynavax Technologies' Change in Cash had a median value of $3.4 million in 2022 and averaged $6.7 million.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 3152930.46% in 2021, then tumbled by 64666.28% in 2022.
  • Dynavax Technologies' Change in Cash (Quarter) stood at $189.8 million in 2021, then plummeted by 98.18% to $3.4 million in 2022, then tumbled by 222.49% to -$4.2 million in 2023, then tumbled by 455.75% to -$23.5 million in 2024, then soared by 360.66% to $61.1 million in 2025.
  • Its Change in Cash stands at $61.1 million for Q3 2025, versus $47.4 million for Q2 2025 and -$44.2 million for Q1 2025.